title: Early-stage biotech companies: strategies for survival and growth.
abstract: The promise of start-up biotechnology companies is enormous. So are the risks and the uncertainty of product development. The authors present a checklist for young biotech companies, covering environmental factors, alliances, and strategic planning.
authors: Director of Corporate Development, Sequella Inc., Rockville, Md.
authors: Wendy
authors: W
authors: Tsai
authors: Stanford
authors: S
authors: Erickson